Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
Diane Rushlow(University Health Network), Brenda L. Gallie(University of Toronto), Timothy W. Corson(Indiana University Health), Josephine C. Dorsman(Dutch Cancer Society), Paul C. Boutros(University of California, Los Angeles), Brigitte L. Thériault(Ontario Institute for Cancer Research), Clarellen Spencer(University Health Network), Wan L. Lam(University of British Columbia), Renée Pang(Ontario Institute for Cancer Research), Berber M. Mol(Amsterdam UMC Location Vrije Universiteit Amsterdam), Annette C. Moll(Amsterdam UMC Location Vrije Universiteit Amsterdam), Roseline Godbout(College of the Holy Cross), Sanja Pajovic(Hospital for Sick Children), Stephanie S. Yee(University of Kentucky), Nadia L. Prigoda-Lee(Toronto Western Hospital), William Halliday(University of Toronto), Katherine Paton(University of British Columbia), Helen Dimaras(University of Toronto), Dietmar Lohmann(Essen University Hospital), Eldad Zacksenhaus(University Health Network), Zhe Jiang(University Health Network), Anthony Raizis(Howard Hughes Medical Institute), Christine Massey(University of Vermont), Jennifer Y. Kennett(BC Cancer Agency), Claude Houdayer(Inserm)
Cited by 419
Related Papers
The repertoire of mutational signatures in human cancer
|Nature|2020|3.8k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2013|841